Jump to content

SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody EVASION!


Bigbird

Recommended Posts

SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody evasion

By Jocelyn Solis-MoreiraMar 18 2021

 

A recent study by researchers in Switzerland, China and the UK found that the Pfizer-BioNTech mRNA vaccine had limited efficacy in identifying mutated receptor-binding domains (RBDs) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein similar to the B.1.351 and P.1 variants.

The B.1.351 variant was first detected in South Africa, and the P.1 variant in Brazil. Both variants have the E484K mutation, which decreases the neutralizing antibody response produced by vaccines, monoclonal antibody therapies, convalescent plasma, and natural infection.

 

Read more

https://www.news-medical.net/news/20210318/SARS-CoV-2-variants-with-E484K-mutation-show-mRNA-vaccine-induced-antibody-evasion.aspx

 

 

 

 

Edited by Bigbird
  • Full Of Win 1
  • Wahaha 1
Link to comment
Share on other sites

  • Bigbird changed the title to SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody EVASION!
10 hours ago, Homelander said:

 

How about eat atb pgd? Can 以毒攻毒?Wahaha

 

based on live human trial conducted by our esteemed pgd sexpert, dr kgk xdd @HarrisY on himself, atb pgd indeed maybe a good vaccine.

 

he been eating atb pgd on a once weekly basis and is exposed to mangalas unprotected, yet he is not infected with wuhan.

 

so theoretically, atb pgd is indeed a highly effective preventive medication. 

Edited by socrates469bc
  • Wahaha 1
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

Mugentech.net uses cookies to ensure you get the best experience on our website. By using this site you agree to Privacy Policy